← All enrolling studies
SYNERGY-Outcomes Study
Metabolic-associated steatotic liver disease (MASLD)
Location: Pennington, NJ
Check Your Eligibility
Or call us at (215) 676-6696
About this study
Are you living with liver disease?
The SYNERGY-Outcomes study is a clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help people with a type of liver disease called metabolic-associated steatotic liver disease, or MASLD.
You will not need to have a liver biopsy during screening visit for this study.
Key eligibility
- Are 18 years of age or older
- Have type 2 diabetes, or do not have type 2 diabetes
- Have problems with your liver
- Are at risk for developing serious liver conditions
Key criteria only. Our team confirms full eligibility when you connect with us.
Check Your Eligibility
Or call us at (215) 676-6696.